Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7432 p763
23/30 December 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Modest intake of cranberry juice OK with warfarin

Dreamstime.com

Cranberry juice

Patients on warfarin advised to drink cranberry juice in moderation

The significance of an interaction between cranberry juice and warfarin has been called into question by the authors of a recent study (Journal of the American Dietetic Association 2006;106:2057).

Researchers randomised seven men stabilised on warfarin to receive one week of cranberry juice (250ml per day) followed, after one week’s washout, by a week of placebo drink, or vice versa. They found no significant changes in international normalised ratio (INR) for either group for all test points in the study.

The authors say that, despite the small sample size, it is clear that a cranberry juice interaction is not a general effect in every patient taking anticoagulants.

However, the authors say: “The study does not eliminate the possibility of idiosyncratic susceptibility to the effects of cranberry juice on warfarin metabolism in individuals with genetic polymorphisms of the cytochrome P450 system.”

They suggest that modest consumption of cranberry products and routine INR monitoring be emphasised to patients.

The Medicines and Healthcare products Regulatory Agency’s most recent advice (October 2004) states: “It is not possible to define a safe quantity or brand of cranberry juice and therefore patients taking warfarin should avoid this drink unless the health benefits are considered to outweigh any risks.” The MHRA says that it is not known whether other cranberry products, such as capsules or concentrates, might interact with warfarin and recommends similar caution with these products.

Back to Top


©The Pharmaceutical Journal